• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Rx Processing Corp. Integrates Prescription Medications and Laboratory Testing, New Unified Ordering System Implemented

Posted on: Tuesday, 28 November 2006, 15:01 CST

Rx Processing Corporation (OTC:RXPC) reaffirms its commitment to under and uninsured citizens in the United States by implementing the long anticipated convergence of prescription medication and laboratory testing product lines into a single unified ordering system. An ability to offer advocates both high value product lines direct to the consumer is a key step in our forward momentum and bolsters the general public's ability to safely attain affordable health care products.

These combined product offerings safe-guard the general public's healthcare via an alternate channel aligned with traditional medical community practices. Our goal: facilitate access to healthcare resources quickly and compliantly. An example order follows: clients on Statin Medications like 'Lipitor' are offered a Lipid Panel or corresponding laboratory test, wherein they can share the laboratory results with their physician and mutually address health care concerns in a more affordable manner. Industry understands Liver function tests are recommended by manufacturers every 6 months for consumers on Statin medications which often go unchecked for a variety of reasons and can be damaging to an individuals overall health care.

"Our proprietary prescription medication and laboratory diagnostic ordering system is a significant step forward in progressively delivering health care products," stated Peter Fiorillo. "The formative years are rapidly passing and our return to full operations is imminent in the near term."

View developmental website at http://dev.rxprocessingcorp.com.

O/S: 61,633,577

Float: 21,744,502

Shareholders: 455

Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.

Source: Business Wire

More News in this Category